PharmExec | Page 3

Featured Content

Pharmaceutical Executive March 2023

Check out the latest features and columns!

The Pivot to Digital

March's Executive Profile features Davidek Herron, Global Head of Digital, Roche

Focus and Fundamentals: CFO Strategies on the Journey to Commercialization

Chief financial officers and other finance experts discuss the continued market volatility impacting life sciences investment—and what biopharma companies can do to help accelerate its recovery. Quality science and “good data” still win the day

Testing the Limits

Pharm Exec's 18th Annual Pipeline Report focuses on spinal muscular atrophy, hemophilia A, intranasal and inhaled vaccines, gene-targeted therapy, and RNA therapeutics

Generative AI’s Breakthrough Potential in Pharma Marketing

March 10, 2023

How platforms like ChatGPT could transform engagement models.

The Challenge of Taking on Falsified Medicines in Europe

March 10, 2023

Region’s diversity plays against efforts to curtail counterfeit drugs.

Vaccine Development Builds on COVID-19 Breakthroughs

March 10, 2023

New candidates are targeting cancer, infectious diseases, and RSV.

Key Opinions Abound

March 10, 2023

While KOLs have been present in healthcare marketing for some time, DOLs are now emerging.

Organon Launches “Her Plan is Her Power,” a New Global Initiative to Reduce Unplanned Pregnancies Where Need is Great and Disparities Exist

March 08, 2023

Building on Organon’s prior FP2030 commitment, the company announces $30 million in new funding to fuel global action and community-driven solutions needed by the 121 million women and girls who experience unplanned pregnancies each year.